# IP Strategy Holdings, Inc.: overview
IPST · Nasdaq · CIK 1788230 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31
Pages: [Overview](/companies/ipst.md) · [Financials](/companies/ipst/financials.md) · [Filings](/companies/ipst/filings.md) · [Insiders](/companies/ipst/insiders.md)
Latest reported revenue: [$736.3k](/filings/0001788230-26-000085.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001788230-26-000085).
## Last eight quarters
| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,761](/filings/0001788230-25-000175.md) | [3,093 d](/filings/0001788230-26-000046.md) | [1,092](/filings/0001788230-26-000068.md) | [1,322](/filings/0001788230-26-000085.md) | [2,989](/filings/0001788230-25-000175.md) | [4,717 d](/filings/0001788230-26-000046.md) | [1,712](/filings/0001788230-26-000068.md) | [736](/filings/0001788230-26-000085.md) |
| Gross margin | % | [35.8%](/filings/0001788230-25-000175.md) | [11.0% d](/filings/0001788230-26-000046.md) | [24.9%](/filings/0001788230-26-000068.md) | [17.2%](/filings/0001788230-26-000085.md) | [61.3%](/filings/0001788230-25-000175.md) | [68.5% d](/filings/0001788230-26-000046.md) | [68.3%](/filings/0001788230-26-000068.md) | [55.5%](/filings/0001788230-26-000085.md) |
| Operating margin | % | [(118.1%)](/filings/0001788230-25-000175.md) | [(268.8%) d](/filings/0001788230-26-000046.md) | [(224.5%)](/filings/0001788230-26-000068.md) | [(503.0%)](/filings/0001788230-26-000085.md) | [(38.4%)](/filings/0001788230-25-000175.md) | [(2622.6%) d](/filings/0001788230-26-000046.md) | [(3877.6%)](/filings/0001788230-26-000068.md) | [(2014.3%)](/filings/0001788230-26-000085.md) |
| Net margin | % | [(194.9%)](/filings/0001788230-25-000175.md) | [(152.5%) d](/filings/0001788230-26-000046.md) | [(277.8%)](/filings/0001788230-26-000068.md) | [(551.9%)](/filings/0001788230-26-000085.md) | [6566.2%](/filings/0001788230-25-000175.md) | [(6862.0%) d](/filings/0001788230-26-000046.md) | [(3898.1%)](/filings/0001788230-26-000068.md) | [(2098.0%)](/filings/0001788230-26-000085.md) |
| Diluted EPS | $ per share | [(160.41)](/filings/0001788230-25-000175.md) | not reported | [(135.34)](/filings/0001788230-26-000068.md) | [(308.12)](/filings/0001788230-26-000085.md) | [16.97](/filings/0001788230-25-000175.md) | not reported | [(134.70)](/filings/0001788230-26-000068.md) | [(13.30)](/filings/0001788230-26-000085.md) |
| Free cash flow | $k | [(1,105) d](/filings/0001788230-25-000175.md) | [(5,062) d](/filings/0001788230-26-000046.md) | [(2,049)](/filings/0001788230-26-000068.md) | [(709) d](/filings/0001788230-26-000085.md) | [(5,139) d](/filings/0001788230-25-000175.md) | [(7,507) d](/filings/0001788230-26-000046.md) | [(2,453)](/filings/0001788230-26-000068.md) | [(1,644) d](/filings/0001788230-26-000085.md) |
- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.
## Last five fiscal years
| Line item | Unit | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [8.0](/filings/0001788230-25-000048.md) | [8.4](/filings/0001788230-26-000046.md) | [10.1](/filings/0001788230-26-000046.md) |
| Gross margin | % | [27.0%](/filings/0001788230-25-000048.md) | [25.3%](/filings/0001788230-26-000046.md) | [54.9%](/filings/0001788230-26-000046.md) |
| Operating margin | % | [(141.3%)](/filings/0001788230-25-000048.md) | [(177.6%)](/filings/0001788230-26-000046.md) | [(1323.6%)](/filings/0001788230-26-000046.md) |
| Net margin | % | [(461.6%)](/filings/0001788230-25-000048.md) | [8.5%](/filings/0001788230-26-000046.md) | [(1360.9%)](/filings/0001788230-26-000046.md) |
| Diluted EPS | $ per share | [(96.45)](/filings/0001788230-25-000048.md) | [(39.46)](/filings/0001788230-26-000046.md) | [(16.03)](/filings/0001788230-26-000046.md) |
| Free cash flow | $m | [(8.5)](/filings/0001788230-25-000048.md) | [(11.3)](/filings/0001788230-26-000046.md) | [(15.4)](/filings/0001788230-26-000046.md) |
- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.
## Insider purchases and sales
The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ipst/insiders.md)
None in coverage.
## Funds that report holding it
From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Arrington Capital Management, LLC](/funds/2087115.md) | 2026-06-30 | $48.6k | 20,685 | | New +20,685 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $41.8k | 17,783 | | New +17,783 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $29.5k | 12,574 | | New +12,574 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $11.9k | 5,076 | | New +5,076 |
| [a16z Capital Management, L.L.C.](/funds/1540358.md) | 2026-06-30 | $9.7k | 4,137 | | New +4,137 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $5.5k | 2,356 | | New +2,356 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $2.5k | 1,057 | | New +1,057 |
| [Vanguard Global Advisers, LLC](/funds/1811242.md) | 2026-06-30 | $790 | 336 | | New +336 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $729 | 310 | | New +310 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $73 | 31 | | New +31 |
## Recent filings
[All 207 filings](/companies/ipst/filings.md)
| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 09:11 ET | [8-K](/filings/0001788230-26-000091.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001788230-26-000091 |
| 2026-10-23 | 16:08 ET | [10-Q](/filings/0001788230-26-000085.md) | Quarterly report, period 2026-06-30 | 0001788230-26-000085 |
| 2026-09-01 | 17:20 ET | [8-K](/filings/0001788230-26-000079.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001788230-26-000079 |
| 2026-06-25 | 16:18 ET | [8-K](/filings/0001788230-26-000071.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001788230-26-000071 |
| 2026-05-20 | 16:23 ET | [10-Q](/filings/0001788230-26-000068.md) | Quarterly report, period 2026-03-31 | 0001788230-26-000068 |
| 2026-05-14 | 16:59 ET | [8-K](/filings/0001788230-26-000062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001788230-26-000062 |
| 2026-04-29 | 09:54 ET | [DEF 14A](/filings/0001788230-26-000057.md) | Proxy statement, period 2026-06-25 | 0001788230-26-000057 |
| 2026-04-21 | 16:32 ET | [8-K](/filings/0001788230-26-000053.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001788230-26-000053 |
| 2026-04-16 | 16:33 ET | [8-K](/filings/0001788230-26-000050.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001788230-26-000050 |
| 2026-04-14 | 16:19 ET | [8-K](/filings/0001788230-26-000048.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001788230-26-000048 |
## Latest annual report
[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001788230-26-000046.md), filed Apr 14, 2026.
## Forecast league
Not in this season’s league. [This season’s league](/leagues.md)
## About the filer
- CIK: 1788230
- Tickers: IPST
- Exchange: Nasdaq
- SIC code: 2080 Beverages
- State of incorporation: DE
- Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 09:12 ET. No prices; not investment advice.